![annexure – ii](http://s1.studyres.com/store/data/009113447_1-6b741161a730e718d10a66a219f4f74d-300x300.png)
pps
... X-Ray structure of the N-terminal domain (2C6F.pdb) known since 2006 Germinal ACE (tACE) which is soluble shows a high sequence similarity and was used in modified form for crystallization with known inhibitors. Furthermore, structure-based design of new inhibitors is possible as the shape of the bi ...
... X-Ray structure of the N-terminal domain (2C6F.pdb) known since 2006 Germinal ACE (tACE) which is soluble shows a high sequence similarity and was used in modified form for crystallization with known inhibitors. Furthermore, structure-based design of new inhibitors is possible as the shape of the bi ...
Hit-to-lead (H2L) and Lead Optimization in Medicinal Chemistry
... • on-rate affected by diffusion, desolvation, molecular orbital reorientation… • difficult to impact by design • SAR would be entirely empirically driven • on-rate may not be a limiting factor of the P-L complex formation in vivo ...
... • on-rate affected by diffusion, desolvation, molecular orbital reorientation… • difficult to impact by design • SAR would be entirely empirically driven • on-rate may not be a limiting factor of the P-L complex formation in vivo ...
Statement on the use of EFV in children less than 3 years of age
... Statement on the use of Efavirenz in children less than 3 years of age On 02 May 2013, the US Food and Drug Administration (FDA) expanded the indication for efavirenz (EFV) to include paediatric patients at least three months old and weighing at least 3.5 kg. Historically efavirenz has not been used ...
... Statement on the use of Efavirenz in children less than 3 years of age On 02 May 2013, the US Food and Drug Administration (FDA) expanded the indication for efavirenz (EFV) to include paediatric patients at least three months old and weighing at least 3.5 kg. Historically efavirenz has not been used ...
Review Drug chirality: a consideration of the significance
... Figure 2. Biological discrimination between a pair of enantiomers. The enantiomer on the left (a) takes part in three complementary interactions with the active site, whereas that on the right (b) interacts at two sites only. Alternative orientations of the enantiomer (right) to the active site are ...
... Figure 2. Biological discrimination between a pair of enantiomers. The enantiomer on the left (a) takes part in three complementary interactions with the active site, whereas that on the right (b) interacts at two sites only. Alternative orientations of the enantiomer (right) to the active site are ...
STV(])FES O!}{(])CJ(vq POqt£/ffl1flLS
... The term chemotherapy was introduced by Paul Ehrlich to indicate the treatment of microbial disease by the administration of a drug which has a lethal or inhibitory effect on the microbe responsible and was described as a "Magic bullet" which when introduced into the body, would destroy only the bac ...
... The term chemotherapy was introduced by Paul Ehrlich to indicate the treatment of microbial disease by the administration of a drug which has a lethal or inhibitory effect on the microbe responsible and was described as a "Magic bullet" which when introduced into the body, would destroy only the bac ...
Tutorial - 4: Respiratory Drug Development
... Structure (1) is terbutaline, a selective β2 adrenoceptor agonist used as a bronchodilator for the treatment of asthma. Structure (2) is bambuterol, an orally active long acting β2adrenoceptor agonist used in the treatment of asthma. Terbutaline has short duration of action due to the enzymati ...
... Structure (1) is terbutaline, a selective β2 adrenoceptor agonist used as a bronchodilator for the treatment of asthma. Structure (2) is bambuterol, an orally active long acting β2adrenoceptor agonist used in the treatment of asthma. Terbutaline has short duration of action due to the enzymati ...
Antibiotics
... a lower affinity than the third-generation cephalosporins for certain chromosomal beta-lactamases of gram-negative bacilli. – Similar activity to cefotaxime and ceftriaxone against pneumococci (including penicillin-intermediate strains) and oxacillin-sensitive S. aureus. – Active against the Enterob ...
... a lower affinity than the third-generation cephalosporins for certain chromosomal beta-lactamases of gram-negative bacilli. – Similar activity to cefotaxime and ceftriaxone against pneumococci (including penicillin-intermediate strains) and oxacillin-sensitive S. aureus. – Active against the Enterob ...
Peptidomimetic Therapeutic Agents Targeting the
... been made in the design of peptidomimetic drugs for the treatment of viral infections, despite the stigma of poor drug-like properties, low oral absorption, and high clearance associated with such compounds. This Account summarizes the progress made toward overcoming such liabilities and highlights ...
... been made in the design of peptidomimetic drugs for the treatment of viral infections, despite the stigma of poor drug-like properties, low oral absorption, and high clearance associated with such compounds. This Account summarizes the progress made toward overcoming such liabilities and highlights ...
CDAS|Safety Pharmacology
... Database (SED). Our SED contains profile data for more than 2,300 compounds including marketed, failed, withdrawn, and OTC drugs as well as reference agents, agrochemicals and natural product compounds which have been screened through 65 ligand binding and enzyme assays. The result is a highly enric ...
... Database (SED). Our SED contains profile data for more than 2,300 compounds including marketed, failed, withdrawn, and OTC drugs as well as reference agents, agrochemicals and natural product compounds which have been screened through 65 ligand binding and enzyme assays. The result is a highly enric ...
Abacavir Regimen - WHO archives
... Côte d’Ivoire, offer antiretroviral therapy. Of the patients who received therapy, 72% were heavily symptomatic upon initiation. Nonetheless, the overall survival rate of was 93% at 6 months, 90% at 12 months, and 86% at 18 months. When survival rates are re-calculated using a worst-case scenario in ...
... Côte d’Ivoire, offer antiretroviral therapy. Of the patients who received therapy, 72% were heavily symptomatic upon initiation. Nonetheless, the overall survival rate of was 93% at 6 months, 90% at 12 months, and 86% at 18 months. When survival rates are re-calculated using a worst-case scenario in ...
Hydrophobic interactions of phenoxazine modulators with bovine
... the BSA molecules in solution. Glasser and Krieglstein 3 correlated the log10P of some phenothiazine drugs and related compounds to their log (b/a) values, b and a being the fractions of bound drug and free drug respectively. A fairly good linear correlation (r = 0⋅969) for five 10-dimethylaminoprop ...
... the BSA molecules in solution. Glasser and Krieglstein 3 correlated the log10P of some phenothiazine drugs and related compounds to their log (b/a) values, b and a being the fractions of bound drug and free drug respectively. A fairly good linear correlation (r = 0⋅969) for five 10-dimethylaminoprop ...
A Pharmacokinetic-Pharmacodynamic Model to Optimize
... sources: concentration-time profiles from healthy volunteers, HIV-1 RNA plasma levels from another investigational compound with a different mechanism of action, and maraviroc in vitro viral inhibition (IC50). Technical details regarding the PK-PD-Disease model are given elsewhere.8,9 Later, when cl ...
... sources: concentration-time profiles from healthy volunteers, HIV-1 RNA plasma levels from another investigational compound with a different mechanism of action, and maraviroc in vitro viral inhibition (IC50). Technical details regarding the PK-PD-Disease model are given elsewhere.8,9 Later, when cl ...
From the lead compound to the drug
... somatic ACE (sACE) is a membrane bound protein (no X-Ray structure yet) Germinal ACE (tACE) which is soluble shows a high sequence similarity and was used in modified form for crystallization with known inhibitors. Furthermore, structure-based design of new inhibitors is possible as the shape of the ...
... somatic ACE (sACE) is a membrane bound protein (no X-Ray structure yet) Germinal ACE (tACE) which is soluble shows a high sequence similarity and was used in modified form for crystallization with known inhibitors. Furthermore, structure-based design of new inhibitors is possible as the shape of the ...
Review - Sociedade Brasileira de Química
... members of the phylum are parasites. They do not have a set body plan like the other parasitic protozoans, although they are characterized by having complex life-cycles with an alternation of sexual and asexual generations. The most well known of all the sporozoans are the organisms which cause the ...
... members of the phylum are parasites. They do not have a set body plan like the other parasitic protozoans, although they are characterized by having complex life-cycles with an alternation of sexual and asexual generations. The most well known of all the sporozoans are the organisms which cause the ...
No Slide Title
... The discovery and development process required to bring new drugs to market is both time consuming and expensive. Although recent practices such as high throughput screening and combinatorial chemistry have increased the number of compounds secured at early phases of drug discovery, this has not tra ...
... The discovery and development process required to bring new drugs to market is both time consuming and expensive. Although recent practices such as high throughput screening and combinatorial chemistry have increased the number of compounds secured at early phases of drug discovery, this has not tra ...
6 Synergy and polyvalence: paradigms to explain the activity of herbal products
... an extract of a plant gives a greater (or safer) response than an equivalent dose of the compound considered to be the ‘active’ one. An example of this is the much improved antispastic effect shown by cannabis extract compared with an equivalent dose of tetrahydrocannabinol (Baker et al., 2000; Will ...
... an extract of a plant gives a greater (or safer) response than an equivalent dose of the compound considered to be the ‘active’ one. An example of this is the much improved antispastic effect shown by cannabis extract compared with an equivalent dose of tetrahydrocannabinol (Baker et al., 2000; Will ...
Evidence-based guideline: Antiepileptic drug selection
... taking ARVs. Patients receiving phenytoin may require a lopinavir/ritonavir dosage increase of ⬃50% to maintain unchanged serum concentrations (Level C). Patients receiving valproic acid may require a zidovudine dosage reduction to maintain unchanged serum zidovudine concentrations (Level C). Coadmi ...
... taking ARVs. Patients receiving phenytoin may require a lopinavir/ritonavir dosage increase of ⬃50% to maintain unchanged serum concentrations (Level C). Patients receiving valproic acid may require a zidovudine dosage reduction to maintain unchanged serum zidovudine concentrations (Level C). Coadmi ...
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS
... • Boosted PI + 2 NRTIs, indicated by genotype results, was used as 2ndline regimen • At 6, 12, 24, and 36 months of 2nd-line ART, – 67%, 62%, 84%, and 90% achieved HIV RNA <50 copies/mL ...
... • Boosted PI + 2 NRTIs, indicated by genotype results, was used as 2ndline regimen • At 6, 12, 24, and 36 months of 2nd-line ART, – 67%, 62%, 84%, and 90% achieved HIV RNA <50 copies/mL ...
Straight Tox 2C phenethylamines
... To see a world in a grain of sand, And a heaven in a wild flower, Hold infinity in the palm of your hand, And eternity in an hour. _ William Blake I found this opening stanza from William Blake’s poem Auguries of Innocence, while looking for some clever way to use the letters “2C” as the words “to s ...
... To see a world in a grain of sand, And a heaven in a wild flower, Hold infinity in the palm of your hand, And eternity in an hour. _ William Blake I found this opening stanza from William Blake’s poem Auguries of Innocence, while looking for some clever way to use the letters “2C” as the words “to s ...
Generic legislation of new psychoactive drugs
... basic skeleton, which dramatically increases the number of possible chemical analogues to 100 or more. Moreover, most chemical compounds have a three-dimensional structure that can deform, which implicates additional variations of the parent compound. Analogues with a deviant three-dimensional struc ...
... basic skeleton, which dramatically increases the number of possible chemical analogues to 100 or more. Moreover, most chemical compounds have a three-dimensional structure that can deform, which implicates additional variations of the parent compound. Analogues with a deviant three-dimensional struc ...
Print - Philosophical Transactions of the Royal Society B
... For instance, deoxyartimisinin was successfully prepared from artemisinin in one step using NaBH4 and BF3Et20 in tetrahydrofuran (THF); it showed an eightfold increase in bioactivity in vitro against chloroquine-resistant malaria as compared with artemisinin. a-Artelinic acid is a potent, stable and ...
... For instance, deoxyartimisinin was successfully prepared from artemisinin in one step using NaBH4 and BF3Et20 in tetrahydrofuran (THF); it showed an eightfold increase in bioactivity in vitro against chloroquine-resistant malaria as compared with artemisinin. a-Artelinic acid is a potent, stable and ...
Generic legislation of new psychoactive drugs
... basic skeleton, which dramatically increases the number of possible chemical analogues to 100 or more. Moreover, most chemical compounds have a three-dimensional structure that can deform, which implicates additional variations of the parent compound. Analogues with a deviant three-dimensional struc ...
... basic skeleton, which dramatically increases the number of possible chemical analogues to 100 or more. Moreover, most chemical compounds have a three-dimensional structure that can deform, which implicates additional variations of the parent compound. Analogues with a deviant three-dimensional struc ...
Modern Methods in Drug Discovery
... medicine (which drug and at what dosage), esp. for long term application of certain drugs (hypertension, analgesics, anti-psychotics) and those that possess a narrow ...
... medicine (which drug and at what dosage), esp. for long term application of certain drugs (hypertension, analgesics, anti-psychotics) and those that possess a narrow ...
Discovery and development of non-nucleoside reverse-transcriptase inhibitors
![](https://en.wikipedia.org/wiki/Special:FilePath/RTenzyme-hand.jpg?width=300)
Non-nucleoside reverse-transcriptase inhibitors (NNRTIs) are antiretroviral drugs used in the treatment of human immunodeficiency virus (HIV). NNRTIs inhibit reverse transcriptase (RT), an enzyme that controls the replication of the genetic material of HIV. RT is one of the most popular targets in the field of antiretroviral drug development.Discovery and development of NNRTIs began in the late 1980s and in the end of 2009 four NNRTI had been approved by regulatory authorities and several others were undergoing clinical development. Drug resistance develops quickly if NNRTIs are administered as monotherapy and therefore NNRTIs are always given as part of combination therapy, the highly active antiretroviral therapy (HAART).